Events

2002-2003

Big Science Meetings

September October November January February March

Wednesday, March 26th, 2003

Imagine the impact of being able to predict
who will get Osteoarthritis

Dr. Pat Costigan

will present his ideas for future research on 
using gait analysis to predict, monitor and possibly intervene
in the development of Osteoarthritis (OA)

Background to this
BIG SCIENCE MEETING

The gait lab  here at Queen's has been in place for more than 12 years with our first subject tested in January 1990.  Since then we have developed processing and analysis procedures that have turned out to be sensitive to changes in gait mechanics between groups.  We can clearly distinguish between normal volunteers and other populations, such as those with knee osteoarthritis (OA) or between young and elderly.  Recent work has shown that we can predict pre-operatively which patients will receive a hemi and which will receive a total knee implants.  Work on a group of normal volunteers, followed over 5 to 10 years, suggests that gait measure may be able to predict those at risk for the development of knee OA.  These very exciting results suggest that we can use gait analysis to predict, follow and perhaps intervene in the development of OA.  The question is where to go from here.  At present there is little we can do to help those with OA and are more interested in working with those at risk of developing OA.  But who are these people?  Who will progress?  What mechanical factors precipitate progression?  Can we alter those mechanical factors?  Can we slow progression?

Why we would like you to attend

This BIG SCIENCE meeting will focus on generating ideas and collaborations.  We hope you will attend because we believe solutions will be found by bringing the strengths of many disciplines.

About the speaker

Dr. Pat Costigan graduated from the University of New Brunswick with a BSc. in Sports Science in 1980.  He came to Queen's to study under Dr. Gavin Reid in the School of Physical and Health Education.  After graduating with an MSc. and specializing in biomechanics.  Dr. Costigan worked in several departments at Queen's including Physical and Health Education and Mechanical Engineering and the School of Rehabilitation Therapy.  For the most part, this work involved developing gait analysis systems.  In 1993 he was the second applicant to the new PhD. program in Physical and Health Education again working under Dr. Reid.  After graduating he was offered a faculty position within the department.

Return to Top of Page


Wednesday, February 26th, 2003

Workshop - Strategic Development for HMRC

The goal of this workshop will be to pool our research ideas in order to craft a vision for how HMRC will move forward over the next five years as a cohesive, multidisciplinary group.

Return to Top of Page


Wednesday, January 29th, 2003

Dr. Inka Brockhausen and Dr. Mark Harrison
will present their ideas for future research directions on

How do bone cartilage stimulating peptides reprogram cartilage and bone cells?


Background to this
BIG SCIENCE MEETING

Degradation products of structural proteins of connective tissue have a long history as stimulatory growth factor since Urist's pioneering experiments on bone morphogenic proteins. Currently we are collaborating with Millennium Biologix Inc. on a research project, which is examining the effect of a novel class of bone and cartilage stimulating peptides. These growth factors are small peptides which can be directly synthesized and offer several advantages over bone morphogenic proteins. The molecular action of these bone cartilage-stimulating peptides (BCSP) is unknown. However, we hae shown that BCSP alter cell growth and glycosylation.


Why we would like you to attend

The goal of this "Big Science" meeting is to invite additional collaborators to join our research team. This will allow for further investigation into a number of different lines of research. In particular, we are interested in identifying the molecular mechanisms for this novel class of peptides. In addition we wish to utilize these peptides in animal models for osteoporosis, cartilage and bone injury and repair.


Speakers:

Dr. Inka Brockhausen, Associate Professor, Department of Medicine and Department of Biochemistry
Dr. Brockhausen is a glycobiologist and holds a career scientist award from The Arthritis Society. She has received a PhD in Biochemistry from the University of Toronto. In her previous research in the Hospital for Sick Children, Toronto, she studied the enzymes and controls involved in glycoprotein biosynthesis and alterations that occur in disease. Her lab is particularly interested in the effects of inflammatory cytokines and growth factors on the structures and functions of glycoproteins in cells against inflammation and bacterial infections.

Dr. Mark Harrision, Orthopaedic Surgeon
Dr. Mark Harrison is a practicing Orthopaedic Surgeon at Kingston General Hospital and the Chair, Scientific Committee, Human Mobility Research Centre. Dr. Harrison has won numerous awards including the McLaughlin Foundation Fellowship and the PSI Resident Research Award. He has also held research fellowships with Dr. E. Boynton, Institute of Biomaterials, University of Toronto, and he was a Clinical Fellow for Dr. J. P. Waddell, Division of Orthopaedics, St. Michael's Hospital. His research interests include obesity among his knee replacement patients and the bio-reaction of orthopaedic materials.

Return to Top of Page


Wednesday, November 27,2002

Is it possible through in vivo measurements of bone architecture and density to predict fracture risk in patients?


Dr. Keith Pilkey
will present his ideas for future research directions
on a finite element model to predict risk of fracture.


Finite element method (FEM) model to predict fracture risk based on in vivo images of bone architecture and mineral density.

The traditional method for assessing fracture risk in patients is through use of bio-statistical analyses, relying on direct and indirect correlations between various physical, bio-chemical, and descriptive indices. However, given the rapid advance of high-resolution imaging technologies and finite element method (FEM) modelling techniques, it is conceivable that a more deterministic computer model can be developed to predict the fracture risk for a given patient based on in vivo images of bone architecture and mineral density. There are a number of potential clinical applications for this predictive model, including the identification of individuals with osteoporosis/osteopenia that are at highest risk for future fracture and the evaluation (with regards to fracture risk) of changes in bone architecture that occur with different therapies in both males and females.

About the speaker:
Dr. Keith Pilkey is an Assistant Professor in the Department of Mechanical Engineering, a Principal Investigator at the Centre for Automotive Materials and Manufacturing (CAMM), and a member of the National Centre of Excellence program on the Automobile of the 21st Century (AUTO21). His general research interests concern the study and prediction of failure behaviour in materials subject to applied loads. Specifically, he has developed image analysis techniques and finite element method (FEM) models, which use real microstructural data to predict failures in aluminum alloys and steels during a variety of sheet forming processes. He believes that this research methodology can also be applied to biological systems, such as the prediction of fracture risk based on in vivo measures of bone architecture and density.

 

Return to Top of Page


Wednesday, October 23, 2002

Dr. Tim Bryant, Dept. of Mechanical Engineering, Queen's University

"Fundamental Mechanisms in the Response of Biological Systems to Mechanical Stimuli"


The response of tissue to mechanical loading underlies a number of processes including remodelling of bone, soft tissue healing, cartilage growth and cartilage degeneration. Currently, a large number of studies are addressing the so-called concept of mechano-transduction - how cells sense and respond to mechanical stimuli such as stress or strain state. However, there are no clear models that link the mechanical, biochemical, and biological pathways that have been observed. This knowledge could identify strategies to solve currently intractable problems such as: providing engineered soft tissue of sufficient strength to be useful, identifying methods of mitigating cartilage damage in osteoarthritis, and developing strategies to limit bone strength loss due to osteoporosis.

This session is intended to be an initial discussion of approaches to studying the general problem of how cells respond to mechanical stimuli. Of particular interest are strategies that blend mechanical and biochemical principles, possibly at the level of the cell membrane. All ideas are welcomed, and people with interests in mechanical engineering, tissue engineering, pharmacology, biochemistry, biology, rheumatic diseases and orthopaedics are all encouraged to bring their ideas.

Return to Top of Page


Wednesday, September 25, 2002

Dr. Mark Harrison is a practicing Orthopaedic Surgeon at Kingston General Hosital and chair of the Scientific Committee at the Human Mobility Research Centre. Dr. Harrison has won numerous awards including the McLaughlin Foundation Fellowship and the PSI Resident Research Award. He has also held research fellowships with Dr. E. Boynton, Institute of Biomaterials, University of Toronto, and he was a Clinical Fellow for Dr. J.P. Waddell, Division of Orthopaedics, St. Michael's Hospital. His research interests include obesity among his knee replacement patients and the bio-reaction of orthopaedic materials.

"Obese patients need to lose weight to improve their health outcomes - but despite good intentions, doctor's orders, and a multi-million dollar weight loss industry - the success rates are low."

Obesity represents a significant risk factor for the develoment of knee arthritis in patients undergoing surgery, as well as for various co-morbidities that affect their quality of life and create pressure on the health system. The perception of orthopaedic surgeons is that obesity increases the risk of complications and has negative impact on the beneficial effects of surgery. Despite being informed of their increased risks and told to lose weight before surgery, patients rarely do so.

The reasons obese patients do not lose weight are being probed through a survey conducted at HMRC under the leadership of Dr. Mark Harrison. This survey examines patient attitudes and their understanding of the relationship betwen obesity and knee arthritis. Are there 'perceptual' differences between obese and non-obese patients in their expectations and understanding of complications following surgery? Do they differ in locus of control? Can we capture these differences through self-report in quality of life scores or psychometric tests? Do they suffer from 'magical thinking' and assume "the Doctor" can fix anything, regardless of whether they can or do help themselves?

We hope the information gained from this survey will help us develop programs to help the obese successfully lose weight, reduce surgical risk and improve their quality of life.


Powerpoint presentation by Dr. Harrison

Return to Top of Page


Return to main page for Events



For further information please contact:

Human Mobility Research Centre
Angada 1
Syl and Molly Apps Research Centre
Kingston General Hospital
Kingston, Ontario K7L 2V7
Telephone (613) 548-2430
Fax (613) 549-2529
hmrc@post.queensu.ca